Other Names for this Disease
- Myelodysplastic/myeloproliferative neoplasm
- ClinicalTrials.gov lists trials that are studying or have studied Myelodysplastic/myeloproliferative disease. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies.
|Generic Name||Imatinib mesylate|
(Novartis Pharmaceuticals Corp.)
The FDA has approved this product to be used in this manner.
|Treatment of adult patients with myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR (platelet-derived growth factor receptor)|
|More Information about this product||Drug Information Portal|